This new mechanism conferring genetic obesity risk whereby variants in FTO directly affect adipocyte function through the activation of IRX3 and IRX5 was previously discovered in lean adults by Claussnitzer et al. [56]. This evidence concerns the gene FTO and obesity disorder.